Winter-van Rossum, Inge; Slot, Margot I. E.; van Hell, Hendrika H.; Bossong, Matthijs G.; Berger, Gregor; Aschauer, Harald; Maat, Arija; Walitza, Susanne; Lavan, Orly; Baeza, Inmaculada; Dolz, Montserrat; Monducci, Elena; Nastro, Paolo Fiori; Kroken, Rune Andreas; Lawrie, Stephen M.; Diaz-Caneja, Covadonga Martinez; Renner, Tobias; Schlogelhofer, Monika; Scharinger, Christian; Spalletta, Gianfranco; Banaj, Nerisa; Otero, Soraya; Schipper, Maria; Brink-Kwakkel, Dorieke; PURPOSE Study Grp, Miriam; Kahn, Rene S.

Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine

精神分裂症谱系障碍的缓解：阿米斯利普利、阿立哌唑和奥氮平的随机对照试验

SCHIZOPHRENIA RESEARCH

IF3.5

2024-09-012

OAAI

Cellular adhesion molecules in drug-naïve and previously medicated patients with schizophrenia-spectrum disorders

SCHIZOPHRENIA RESEARCH

IF3.5

2024-05-011

OAAI

Association between cytokines and suicidality in patients with psychosis: A multicentre longitudinal analysis

brain behavior and immunity

IF3.5

2024-05-011

OAAI

Risk factors for mortality in patients admitted to a psychiatric acute ward: A prospective cohort study

Acta Psychiatrica Scandinavica

IF5

2024-01-150

USING LIPIDOMIC PROFILING TO EXPLORE ANTIPSYCHOTIC EFFECTS IN SCHIZOPHRENIA

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2023-10-010

PRE

Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study

GENERAL HOSPITAL PSYCHIATRY

IF3.7

2023-07-011

OAAI

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial

BMC PSYCHIATRY

IF3.6

2023-06-292

OAAI

Depression trajectories and cytokines in schizophrenia spectrum disorders- A longitudinal observational study

SCHIZOPHRENIA RESEARCH

IF3.5

2023-02-016

OAAI

Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation

BIOLOGICAL PSYCHIATRY

IF9

2023-01-0121

OAAI

Sheikh, Mashhood A.; O'Connell, Kevin S.; Lekva, Tove; Szabo, Attila; Akkouh, Ibrahim A.; Osete, Jordi Requena; Agartz, Ingrid; Engh, John A.; Andreou, Dimitrios; Boye, Birgitte; Boen, Erlend; Elvsashagen, Torbjorn; Hope, Sigrun; Werner, Maren Caroline Frogner; Joa, Inge; Johnsen, Erik; Kroken, Rune A.; Lagerberg, Trine Vik; Melle, Ingrid; Drange, Ole Kristian; Morken, Gunnar; Naerland, Terje; Sorensen, Kjetil; Vaaler, Arne E.; Weibell, Melissa Authen; Westlye, Lars T.; Aukrust, Pal; Djurovic, Srdjan; Steen, Nils Eiel; Andreassen, Ole A.; Ueland, Thor

Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness

SCHIZOPHRENIA BULLETIN

IF4.8

2022-12-0310

Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2022-10-014

OAAI

Rune A. Kroken

个人简介

教育背景

工作经历

荣誉奖项

研究方向